Literature DB >> 18231574

Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cells.

Mark J Paul-Clark1, Rosalinda Sorrentino, Lucy K Bailey, Shiranee Sriskandan, Jane A Mitchell.   

Abstract

We have recently demonstrated that oxidants can activate monocytes via an action on Toll-like receptor (TLR) 2; however, it is unclear what functional consequence this has on immune surveillance for Gram-negative and -positive bacteria. Gram-negative and -positive bacteria and their related pathogen-associated molecular patterns (PAMPs) are sensed by TLR4 and TLR2, respectively. In the current study, we used a human monocyte cell line to show that oxidants prime cells to subsequent challenge with Gram-negative or -positive bacteria as well as PAMPs specific for TLR4 (LPS), TLR2/1 (Pam(3)CSK4), TLR2/6 (FSL-1), Nod1 (FK565), and Nod2 (MDP Lys 18). Similarly, activation of TLR4 with LPS primed for subsequent activation of cells by agonists of the TLR2/6 or TLR2/1 complex. However, no synergy was noted when cells were costimulated with Pam(3)CSK4 and FSL-1. We then tested blood (and isolated monocytes) derived from healthy smokers, which is oxidant primed, making it more sensitive to bacterial or PAMP stimulation when compared with blood of nonsmokers. Thus an oxidant stimulation, possibly via an action on TLR2 or associated transduction pathways, provides a signal that initiates inflammatory responses and sensitizes cells to pathogenic insults.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18231574      PMCID: PMC2215766          DOI: 10.2119/2007-00098.Paul-Clark

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  33 in total

1.  Serine protease inhibitors modulate chemotactic cytokine production by human lung fibroblasts in vitro.

Authors:  Hiroki Numanami; Sekiya Koyama; Esturo Sato; Masayuki Haniuda; Dan K Nelson; Jeffrey C Hoyt; Jon L Freels; Michael P Habib; Richard A Robbins
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-12-13       Impact factor: 5.464

2.  Cigarette smoke-induced endothelium dysfunction: role of superoxide anion.

Authors:  L Raij; E G DeMaster; E A Jaimes
Journal:  J Hypertens       Date:  2001-05       Impact factor: 4.844

3.  Acute effects of smoking of cigarettes with different tar content on plasma oxidant/antioxidant status.

Authors:  I Durak; N K Bingöl; A Avci; M Y Cimen; M Kaçmaz; L Karaca; H S Oztürk
Journal:  Inhal Toxicol       Date:  2000-07       Impact factor: 2.724

4.  Role of TLR-2 in the activation of nuclear factor kappaB by oxidative stress in cardiac myocytes.

Authors:  S Frantz; R A Kelly; T Bourcier
Journal:  J Biol Chem       Date:  2000-11-16       Impact factor: 5.157

5.  Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Authors:  Richard E K Russell; Sarah V Culpitt; Carmen DeMatos; Louise Donnelly; Michael Smith; John Wiggins; Peter J Barnes
Journal:  Am J Respir Cell Mol Biol       Date:  2002-05       Impact factor: 6.914

Review 6.  Oxidatively modified proteins in aging and disease.

Authors:  M Flint Beal
Journal:  Free Radic Biol Med       Date:  2002-05-01       Impact factor: 7.376

7.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

Review 8.  Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease.

Authors:  Jane A Mitchell; Mark J Paul-Clark; Graham W Clarke; Shaun K McMaster; Neil Cartwright
Journal:  J Endocrinol       Date:  2007-06       Impact factor: 4.286

9.  Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages.

Authors:  A Koch; M Giembycz; R G Stirling; S Lim; I Adcock; K Wassermann; E Erdmann; K F Chung
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

10.  Immune response in asymptomatic smokers.

Authors:  A Zeidel; B Beilin; I Yardeni; E Mayburd; G Smirnov; H Bessler
Journal:  Acta Anaesthesiol Scand       Date:  2002-09       Impact factor: 2.105

View more
  7 in total

1.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: neonatal immune function and vaccine responses in children born in low-income versus high-income countries.

Authors:  A H J van den Biggelaar; P G Holt
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

2.  Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin.

Authors:  Tian Lin; Young Ho Kwak; Fatima Sammy; Ping He; Sujatha Thundivalappil; Guangjie Sun; Wei Chao; H Shaw Warren
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

3.  Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae-induced Th2 inflammatory responses.

Authors:  Rosalinda Sorrentino; Pearl Gray; Shuang Chen; Kenichi Shimada; Timothy R Crother; Moshe Arditi
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-09       Impact factor: 6.914

Review 4.  Therapeutic targeting of NOD1 receptors.

Authors:  L Moreno; T Gatheral
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

5.  Toll-like receptor 4-mediated nuclear factor kappa B activation is essential for sensing exogenous oxidants to propagate and maintain oxidative/nitrosative cellular stress.

Authors:  Rajendra Karki; Orisa J Igwe
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

6.  Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach.

Authors:  Clare L Ross; Neil Galloway-Phillipps; Paul C Armstrong; Jane A Mitchell; Timothy D Warner; Christopher Brearley; Mari Ito; Tanushree Tunstall; Sarah Elkin; Onn Min Kon; Trevor T Hansel; Mark J Paul-Clark
Journal:  BMJ Open       Date:  2015-01-28       Impact factor: 2.692

7.  Role of the inflammasome in chronic obstructive pulmonary disease (COPD).

Authors:  Chiara Colarusso; Michela Terlizzi; Antonio Molino; Aldo Pinto; Rosalinda Sorrentino
Journal:  Oncotarget       Date:  2017-05-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.